欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/0530/004
药品名称Treposa 10 mg/ml solution for infusion
活性成分
    • treprostinil 10.0 mg/ml
剂型Solution for infusion
上市许可持有人Amomed Pharma GmbH Leopold Ungar Platz 2 1190 Vienna Austria
参考成员国 - 产品名称Austria (AT)
Treposa 10 mg/ml Infusionslösung
互认成员国 - 产品名称
    • Denmark (DK)
      Tresuvi
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
      TREPROSTINIL/DIAPHARM
    • Norway (NO)
      Tresuvi
    • Finland (FI)
    • Poland (PL)
      Tresuvi
    • Hungary (HU)
      TRESUVI 10 mg/ml oldatos infúzió
    • Bulgaria (BG)
      Treprostinil Diapharm
    • Czechia (CZ)
      Treprostinil Diapharm 10 mg/ml Infuzní roztok
    • Romania (RO)
    • Slovakia (SK)
      Tresuvi 10 mg/ml infúzny roztok
    • Slovenia (SI)
      Treprostinil Amomed 10 mg/ml raztopina za infundiranje
许可日期2019/08/05
最近更新日期2024/07/19
药物ATC编码
    • B01AC21 treprostinil
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase